Dare to Push Women's Health Forward

Bioscience that’s 100% for her.

At Daré Bioscience, every female-focused innovation is born in the lab. We’re a purpose-driven health biotech company conducting end-to-end clinical development of targeted therapeutics that women deserve. We’re relentlessly closing the gap in care—and opening new doors to health and healing.

Driven by science and trusted by OB/GYNs and women’s health providers nationwide, we aim to deliver revolutionary solutions for women of all ages.

We don’t wait for change. We create it.

A Clinically-Studied Female Arousal Cream

A first-of-its-kind topical female arousal cream—backed by science and designed to improve sexual health: DARE to PLAY™ Sildenafil Cream – now available for pre-fulfillment prescriptions in all 50 states.

Vaginal Probiotic Capsule

Restore balance to your vaginal microbiome with DARE to RESTORE™ Flora Sync LF5™.

Invest in a Company Focusing on a Long-Overdue Correction in Women’s Health

For too long, women’s health has been underfunded and under-researched. More than an investment—join a movement working to transform women’s health.

Our Ongoing Clinical Trials

Explore Daré Bioscience’s life-changing solutions currently in development—with innovations to meet women’s health needs at every life stage.

Our Product Lines—

Built by Biotech, Designed for Her

We combine advanced science, education and advocacy to bring women’s health needs into clear, clinical focus—developing targeted therapeutics for conditions that the medical establishment has dismissed, ignored and underfunded. From contraception to menopause, we’re daring to put her health first.

DARE
to
PLAYTM

Designed for her sexual experience

DARE
to
RESTORETM

Designed to maintain a healthy vaginal microbiome

DARE
to
RECLAIMTM

Designed to help her keep living her best life

DARE
to
SUPPORTTM

Designed to support her pregnancy

DARE
to
PLANTM

Designed for her contraceptive needs

DARE
to
FIGHTTM

Designed to treat vaginal infections

DARE
to
PLAYTM

Designed for her sexual experience

DARE
to
RESTORETM

Designed to maintain a healthy vaginal microbiome

DARE
to
RECLAIMTM

Designed to help her keep living her best life

DARE
to
SUPPORTTM

Designed to support her pregnancy

DARE
to
PLANTM

Designed for her contraceptive needs

DARE
to
FIGHTTM

Designed to treat vaginal infections

“Science-backed treatments shouldn’t get lost in bureaucracy while women continue to go without options they can trust.”

Sabrina Martucci Johnson

Founder & Chief Executive Officer of Daré Bioscience

Women need real medicine—not marketing gimmicks.

It’s harder than ever for people to sift through misleading messaging and distinguish real solutions from modern-day snake oil. And the impacts are widespread: Especially in areas such as vaginal health and sexual wellness, women waste time, money, and energy while real solutions get lost in the crowd, and the whole field suffers from eroded trust.

Here’s how to tell the difference between credible innovation and clever marketing:

Study ≠ Science

If there’s no control group, no blinding, no peer review—it is probably junk science.

Claims ≠ Credibility

“Clinically proven” has become a marketing phrase. Ask: What was measured? How big was the effect? Was it published in a scientific journal?

Trendy ≠ Trustworthy

Social media is full of snake oil. Real solutions come from understanding biology, not just branding.

We are here to change what women expect from their health care—and what they demand from the products they use. Want to Be a Smarter Consumer? Ask the hard questions, expect better data, and look for companies that don’t just say “science”—they show it.

Because “good enough” isn’t good enough.

The Daré Approach: Science That Meets Our Standards

We're On a Mission

From in-depth research to real-world results, we’re committed to changing women’s lives by revolutionizing their health.

FDA-Approved Product

Completed Clinical Trials Submitted to the FDA

$ 0 million

Spent on Women’s Health Research + Product Development

0 +

Peer-Reviewed Publications

Making Headlines

Daré’s women’s health innovations are being recognized across media and industry publications.

Fueling Progress, One Insight at a Time

Dive into the latest news, peer-reviewed publications, and clinical trials shaping the future of women’s health.

News + Press Releases, Pipeline Information

Press Release: Daré Bioscience Announces the Upcoming Launch of Flora Sync LF5™ Vaginal Probiotic Capsules

First Product Revenue Expected This Month, Opening New Commercial Chapter for Women’s Health Innovator. Limited-Time Launch Offer: 30% Off + Free Shipping.

June 4, 2026

News + Press Releases

Press Release: Daré Bioscience Receives NIH Funding Award Notice to Advance DARE-HPV, its Novel Investigational Treatment for Persistent High-Risk HPV Infection, the Most Common Cause of Cervical Cancer

• Receipt of award notice for second $1.0 million tranche of NIAID funding brings total NIH funding award for DARE-HPV to $2.0 million. • Funding award milestone follows Daré’s announcement last week of the initiation of its Phase 2 clinical study of DARE-HPV — representing the first time women with persistent high-risk HPV infection may have access to this pharmacologic treatment as part of a clinical trial. • DARE-HPV targets high-risk HPV infection, the cause of virtually all cervical cancer cases in the U.S., for which there are currently no FDA-approved pharmacologic treatments. • Award reflects Daré’s strategy of leveraging non-dilutive government funding, including both NIH grants and ARPA-H contract support for DARE-HPV, to advance a differentiated pipeline addressing some of the most persistent unmet needs in women’s health.

May 26, 2026

News + Press Releases

Press Release: Daré Bioscience Initiates Phase 2 Study of DARE-HPV, a Novel Pharmacologic Treatment for Persistent High-Risk HPV Infection with No FDA-Approved Therapies

Each year, an estimated six million women in the United States acquire a high-risk HPV infection — and there are no FDA-approved treatments. DARE-HPV development is backed by a $10 million U.S. government (ARPA-H)-funded contract; topline data readout expected in 2027.

May 18, 2026

News + Press Releases, Pipeline Information

Press Release: Daré Bioscience Announces the Upcoming Launch of Flora Sync LF5™ Vaginal Probiotic Capsules

First Product Revenue Expected This Month, Opening New Commercial Chapter for Women’s Health Innovator. Limited-Time Launch Offer: 30% Off + Free Shipping.

June 4, 2026

News + Press Releases

Press Release: Daré Bioscience Receives NIH Funding Award Notice to Advance DARE-HPV, its Novel Investigational Treatment for Persistent High-Risk HPV Infection, the Most Common Cause of Cervical Cancer

May 26, 2026

News + Press Releases

Press Release: Daré Bioscience Initiates Phase 2 Study of DARE-HPV, a Novel Pharmacologic Treatment for Persistent High-Risk HPV Infection with No FDA-Approved Therapies

May 18, 2026

Dare to Push Women's Health Forward

Bioscience that’s 100% for her.

We don’t wait for change. We create it.

A Clinically-Studied Female Arousal Cream

Vaginal Probiotic Capsule

Invest in a Company Focusing on a Long-Overdue Correction in Women’s Health

Our Ongoing Clinical Trials

Our Product Lines—

Built by Biotech, Designed for Her

DARE to PLAYTM

Designed for her sexual experience

DARE to RESTORETM

Designed to maintain a healthy vaginal microbiome

DARE to RECLAIMTM

Designed to help her keep living her best life

DARE to SUPPORTTM

Designed to support her pregnancy

DARE to PLANTM

Designed for her contraceptive needs

DARE to FIGHTTM

Designed to treat vaginal infections

DARE to PLAYTM

Designed for her sexual experience

DARE to RESTORETM

Designed to maintain a healthy vaginal microbiome

DARE to RECLAIMTM

Designed to help her keep living her best life

DARE to SUPPORTTM

Designed to support her pregnancy

DARE to PLANTM

Designed for her contraceptive needs

DARE to FIGHTTM

Designed to treat vaginal infections

Women need real medicine—not marketing gimmicks.

Here’s how to tell the difference between credible innovation and clever marketing:

Study ≠ Science​

Claims ≠ Credibility

Trendy ≠ Trustworthy​

The Daré Approach: Science That Meets Our Standards

We're On a Mission

Making Headlines

Fueling Progress, One Insight at a Time

Press Release: Daré Bioscience Announces the Upcoming Launch of Flora Sync LF5™ Vaginal Probiotic Capsules

Press Release: Daré Bioscience Receives NIH Funding Award Notice to Advance DARE-HPV, its Novel Investigational Treatment for Persistent High-Risk HPV Infection, the Most Common Cause of Cervical Cancer

Press Release: Daré Bioscience Initiates Phase 2 Study of DARE-HPV, a Novel Pharmacologic Treatment for Persistent High-Risk HPV Infection with No FDA-Approved Therapies

Press Release: Daré Bioscience Announces the Upcoming Launch of Flora Sync LF5™ Vaginal Probiotic Capsules

Press Release: Daré Bioscience Receives NIH Funding Award Notice to Advance DARE-HPV, its Novel Investigational Treatment for Persistent High-Risk HPV Infection, the Most Common Cause of Cervical Cancer

Press Release: Daré Bioscience Initiates Phase 2 Study of DARE-HPV, a Novel Pharmacologic Treatment for Persistent High-Risk HPV Infection with No FDA-Approved Therapies

A first-of-its-kind female arousal cream.

DARE
to
PLAYTM

DARE
to
RESTORETM

DARE
to
RECLAIMTM

DARE
to
SUPPORTTM

DARE
to
PLANTM

DARE
to
FIGHTTM

DARE
to
PLAYTM

DARE
to
RESTORETM

DARE
to
RECLAIMTM

DARE
to
SUPPORTTM

DARE
to
PLANTM

DARE
to
FIGHTTM

Study ≠ Science

Trendy ≠ Trustworthy